A new study shows success in a series of Phase 2 trials.
- A new study in Psychopharmacology shows MDMA has a 50 percent efficacy rate for PTSD victims.
- A series of six controlled, double-blind studies moves research to Phase 3 trials.
- Combined with psychotherapy, MDMA could be a potent force in treating one of the our most challenging problems.
No, depression is not just a type of "affluenza" — poor people in conflict zones are more likely candidates
- Often seen as typical of rich societies, depression is actually more prevalent in poor, conflict-ridden countries
- More than one in five Afghans is clinically depressed – a sad world record
- But are North Koreans really the world's 'fourth least depressed' people?
Taking care of our minds is an often neglected aspect of aging. What are we going to do about it?
- Studies have shown that depression can worsen in our old age.
- Other mental health concerns, too, are not only debilitating on their own but they can often make it more difficult to treat other health conditions.
- However, recent advances in how we treat mental health in the elderly are making a big difference. Here's how.
A recent study could help improve treatments for PTSD, anxiety and phobias.
- A new study examined how the effects of fear-related memories can be silenced in the brain.
- Forming new and positive "extinction memories" can help to silence fearful memories.
- The study found that the hippocampus plays a significant role in "extinction training."
A supervised learning algorithm can predict clinical depression much earlier and more accurately than trained health professionals.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.